📰 Daniel Janney News
Daniel Janney News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Janney. Real-time updates on events, politics, business and more.
August 17, 2023
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) saw a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,330,000 shares, a decline of 7.6% from the July 15th total of 1,440,000 shares. Based on an average daily trading volume, of 324,300 shares, the short-interest […]
August 11, 2023
Krystal Biotech (NASDAQ:KRYS – Free Report) had its price target lifted by Chardan Capital from $148.00 to $153.00 in a research note released on Monday, Marketbeat.com reports. They currently have a buy rating on the stock. Chardan Capital also issued estimates for Krystal Biotech’s FY2023 earnings at ($5.22) EPS and FY2024 earnings at $2.75 EPS. […]
July 6, 2023
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) traded up 2.3% during mid-day trading on Thursday . The stock traded as high as $122.01 and last traded at $122.01. 109,183 shares changed hands during trading, a decline of 57% from the average session volume of 254,385 shares. The stock had previously closed at $119.29. […]
June 14, 2023
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating)’s stock price reached a new 52-week high on Wednesday . The company traded as high as $131.80 and last traded at $130.90, with a volume of 12127 shares. The stock had previously closed at $130.32. Wall Street Analysts Forecast Growth A number of equities analysts have weighed in […]
June 13, 2023
Verition Fund Management LLC boosted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) by 19.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,561 shares of the company’s stock after purchasing an additional 12,909 shares during the […]
June 2, 2023
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $124.23 and last traded at $124.20, with a volume of 389174 shares changing hands. The stock had previously closed at $116.84. Analyst Upgrades and Downgrades KRYS has been the subject […]
June 1, 2023
Advisory Research Inc. lessened its stake in Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 10,354 shares of the company’s stock after selling 465 shares during the quarter. Advisory Research Inc.’s holdings […]
May 28, 2023
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price objective upped by Stifel Nicolaus from $102.00 to $145.00 in a report issued on Wednesday, The Fly reports. A number of other analysts also recently weighed in on the stock. Bank of America boosted their target price on shares of Krystal Biotech from $105.00 to $118.00 […]
May 27, 2023
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price objective lifted by Stifel Nicolaus from $102.00 to $145.00 in a research report released on Wednesday morning, The Fly reports. Several other research analysts have also recently commented on KRYS. William Blair restated an outperform rating on shares of Krystal Biotech in a research report on […]
May 26, 2023
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Equities research analysts at HC Wainwright raised their Q3 2023 earnings per share (EPS) estimates for Krystal Biotech in a research note issued to investors on Monday, May 22nd. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($1.02) per share for […]